Dynamic Technology Lab Private Ltd Increases Stake in 10x Genomics

The investment firm boosted its holdings in the biotech company by 146.7% in the third quarter.

Published on Mar. 9, 2026

Dynamic Technology Lab Private Ltd increased its position in shares of 10x Genomics (NASDAQ:TXG) by 146.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund now owns 96,279 shares of the company's stock, worth $1.13 million.

Why it matters

10x Genomics is a leading provider of advanced genomic analysis solutions, with a focus on single-cell sequencing and spatial genomics. The increase in Dynamic Technology Lab's stake suggests the investment firm sees significant potential in the company's technology and future growth prospects.

The details

According to the SEC filing, Dynamic Technology Lab acquired an additional 57,256 shares of 10x Genomics during the third quarter, bringing its total holdings to 96,279 shares. This represents about 0.08% of the company's outstanding shares.

  • Dynamic Technology Lab increased its stake in 10x Genomics during the third quarter of 2026.

The players

Dynamic Technology Lab Private Ltd

An investment firm that has increased its stake in 10x Genomics, a leading provider of advanced genomic analysis solutions.

10x Genomics

A biotechnology company specializing in advanced genomic analysis solutions, including single-cell sequencing and spatial genomics.

Got photos? Submit your photos here. ›

The takeaway

The increase in Dynamic Technology Lab's stake in 10x Genomics suggests the investment firm sees significant potential in the company's technology and future growth prospects, underscoring the growing importance of advanced genomic analysis solutions in the biotechnology industry.